Skip to main content

Caris Life Sciences, Inc.

For the period ended Jun 30, 2025. Filed Aug 12, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 12, 2025

CAI$25.57+1.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

CARIS LIFE SCIENCES, INC.

FORM 10-Q

TABLE OF CONTENTS

Page
Special Note Regarding Forward-Looking Statements1
Part I - Financial Information
Item 1.Condensed Consolidated Financial Statements (Unaudited)2
Condensed Consolidated Balance Sheets2
Condensed Consolidated Statements of Operations and Comprehensive Loss3
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Shareholders’ Deficit4
Condensed Consolidated Statements of Cash Flows6
Notes to Condensed Consolidated Financial Statements7
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations36
Item 3.Quantitative and Qualitative Disclosures About Market Risk54
Item 4.Controls and Procedures55
Part II - Other Information
Item 1.Legal Proceedings57
Item 1A.Risk Factors57
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds123
Item 3.Defaults Upon Senior Securities124
Item 4.Mine Safety Disclosures125
Item 5.Other Information125
Item 6.Exhibits125
Signatures129
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.